| Period Ending: |
LTM
(Last Twelve Months) |
2021 12-31 |
|---|---|---|
| Report Filing | 2025-08-14 | 2022-03-11 |
| Revenue | 36 | 0 |
| Cost of Revenue | 9.36 | 0 |
| Gross Profit | 26.64 | 0 |
| Operating Expenses | 30.56 | 4.44 |
| Research & Development | 8.4 | 0 |
| Selling, General and Administrative | 19.55 | 4.44 |
| Other Operating Expenses | 2.6 | 0 |
| Operating Income | -3.91 | -4.44 |
| Net Non-Operating Interest | -2.81 | 12.18 |
| Interest Income | 0.04 | 0.036 |
| Interest Expense | 2.85 | -12.14 |
| Equity & Other Income/(Expense) | -10.59 | -0.036 |
| Income Before Tax | -17.31 | 7.71 |
| Income Tax Expense | 0.003 | -12.14 |
| Income Attributable to Non-Controlling Interest | 0 | 0 |
| Net Income | -17.32 | 19.85 |
| Depreciation and Amortization | -11.45 | 12.14 |
| EBITDA | -15.36 | 7.71 |
| Earnings Per Share (EPS) | -1.03 | 0.79 |
| Diluted Earnings Per Share | -0.62 | 0.79 |
| Weighted Average Shares Outstanding | 46.83 | 25 |
| Diluted Weighted Average Shares Outstanding | 46.83 | 25 |
